Free Trial

Indivior (INDV) Insider Trading & Ownership

Indivior logo
GBX 825 -1.50 (-0.18%)
(As of 08:28 AM ET)

Indivior (LON:INDV) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
3.44%
Number Of
Insiders Buying
(Last 12 Months)
2
Amount Of
Insider Buying
(Last 12 Months)
£35,713.67
Number Of
Insiders Selling
(Last 12 Months)
1
Amount Of
Insider Selling
(Last 12 Months)
£424,476.69
Get INDV Insider Trade Alerts

Want to know when executives and insiders are buying or selling Indivior stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

INDV Insider Buying and Selling by Quarter

Indivior Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
7/26/2024Jo Le CouilliardInsiderBuy1,490GBX 1,006£14,989.40
3/18/2024Mark CrossleyInsiderSell10,549GBX 1,617£170,577.33
3/15/2024Mark CrossleyInsiderSell15,444GBX 1,644£253,899.36
12/20/2023Graham HetheringtonInsiderBuy1,743GBX 1,189£20,724.27
(Data available from 1/1/2013 forward)

INDV Insider Trading Activity - Frequently Asked Questions

The list of insiders at Indivior includes Graham Hetherington, Jo Le Couilliard, Mark Crossley, and Mark Stejbach. Learn more on insiders at INDV.

3.44% of Indivior stock is owned by insiders. Learn more on INDV's insider holdings.

The following insiders have purchased INDV shares in the last 24 months: Graham Hetherington (£56,499.27), Jo Le Couilliard (£14,989.40), and Mark Stejbach (£21,028).

Insiders have purchased a total of 7,283 INDV shares in the last 24 months for a total of £92,516.67 bought.

The following insider sold INDV shares in the last 24 months: Mark Crossley (£424,476.69).

Insiders have sold a total of 25,993 Indivior shares in the last 24 months for a total of £424,476.69 sold.

Indivior Key Executives

  • Mr. Mark Crossley
    CEO & Executive Director
  • Mr. Ryan Preblick
    CFO & Executive Director
  • Dr. Christian Heidbreder
    Chief Scientific Officer
  • Mr. Jason Thompson
    Vice President of Investor Relations
  • Ms. Cynthia Cetani
    Chief Integrity & Compliance Officer
  • Mr. Jeffrey W. Burris (Age 52)
    Chief Legal Officer
  • Mr. Jon Fogle
    Chief Human Resources Officer
  • Mr. Richard Simkin
    Chief Commercial Officer
  • Mr. Hillel West
    Chief Manufacturing & Supply Officer
  • Mr. Vishal Kalia
    SVP of US Treatment Access, Support Programs & Business Insights and Chief Impact & Strategy Officer


This page (LON:INDV) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners